Shares outstanding · 2020–2025
Legend Biotech shares outstanding
370M+0.7% · FY2025
Legend Biotech (LEGN) reported 370M in shares outstanding for fiscal 2025, +0.7% year on year.
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2020–2025 compound annual growth +6.8%
Figures are reported under IFRS, in US dollars.
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Legend Biotech shares outstanding |url=https://companiesranked.com/en/company/legend-biotech/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Legend Biotech shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/legend-biotech/shares-outstandingBibTeX
@misc{companiesranked-en-company-legend-biotech-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Legend Biotech shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/legend-biotech/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001801198-26-000008 · March 10, 2026
{{cite web |title=Legend Biotech shares outstanding — 20-F (0001801198-26-000008) |url=https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.